The Top Line
Subscribe in ParasocialFree on the App Store for iPhone, iPad and Mac. No subscription. Once it is installed, tap this link again and the show is yours. Already have it? Open in Parasocial.
About
Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning.
Also on
Recent episodes
- Clinical trials reach a new automation inflection point (Sponsored)
- The future of RAS inhibitors
- The people who stayed with the problem
- Why Diagnostic-Driven Therapies Still Miss Eligible Patients (Sponsored)
- MrBeast, Snapchat, AI and more: Pharma marketing’s pulse check
- What did we learn from Big Pharma’s Q2 results?
- How consumerization is reshaping pharma marketing (Sponsored)
- A genomics library for the AI era
- The next frontier in patient support: Connected data, AI and personalized engagement (Sponsored)
- Novo Nordisk’s CFO on the oral Wegovy rollout and beyond